These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23591601)

  • 21. Brief History of Anti-Doping.
    Ljungqvist A
    Med Sport Sci; 2017; 62():1-10. PubMed ID: 28571021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic use exemptions - serving athlete patients.
    Grimm K; Pillay L; Tabane South African Institute For Drug-Free Sport Therapeutic Use Exemption Committee C
    S Afr Med J; 2019 Jun; 109(7):12656. PubMed ID: 31266568
    [No Abstract]   [Full Text] [Related]  

  • 25. The world anti-doping program and the primary care physician.
    Hilderbrand RL
    Pediatr Clin North Am; 2007 Aug; 54(4):701-11, x-xi. PubMed ID: 17723872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug testing at the 10th Asian Games and 24th Seoul Olympic Games.
    Park J; Park S; Lho D; Choo HP; Chung B; Yoon C; Min H; Choi MJ
    J Anal Toxicol; 1990; 14(2):66-72. PubMed ID: 2325381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticonvulsants in sports: ethical considerations.
    Kaufman KR
    Epilepsy Behav; 2007 Mar; 10(2):268-71. PubMed ID: 17258507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and Development of the List of Prohibited Substances and Methods.
    Kinahan A; Budgett R; Mazzoni I
    Med Sport Sci; 2017; 62():39-54. PubMed ID: 28571027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
    Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
    Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Doping in sport].
    Schänzer W; Thevis M
    Med Klin (Munich); 2007 Aug; 102(8):631-46. PubMed ID: 17694283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of prohibited substances for therapeutic reasons in athletes affected by endocrine diseases and disorders: the therapeutic use exemption (TUE) in clinical endocrinology.
    Di Luigi L; Pigozzi F; Sgrò P; Frati L; Di Gianfrancesco A; Cappa M
    J Endocrinol Invest; 2020 May; 43(5):563-573. PubMed ID: 31734891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The toxic torch of the modern Olympic Games.
    Prendergast HM; Bannen T; Erickson TB; Honore KR
    Vet Hum Toxicol; 2003 Mar; 45(2):97-102. PubMed ID: 12678299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H; Auchus RJ
    Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC; Fitch KD
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating?
    Mottram DR
    Sports Med; 1999 Jan; 27(1):1-10. PubMed ID: 10028129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.